ZA942818B - Method of enhancing thrombolysis. - Google Patents

Method of enhancing thrombolysis.

Info

Publication number
ZA942818B
ZA942818B ZA942818A ZA942818A ZA942818B ZA 942818 B ZA942818 B ZA 942818B ZA 942818 A ZA942818 A ZA 942818A ZA 942818 A ZA942818 A ZA 942818A ZA 942818 B ZA942818 B ZA 942818B
Authority
ZA
South Africa
Prior art keywords
enhancing thrombolysis
thrombolysis
enhancing
Prior art date
Application number
ZA942818A
Other languages
English (en)
Inventor
Leonard Garfinkel
Marian Gorecki
Amos Panet
Original Assignee
Bio Technology General Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Technology General Corp filed Critical Bio Technology General Corp
Publication of ZA942818B publication Critical patent/ZA942818B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
ZA942818A 1993-04-23 1994-04-22 Method of enhancing thrombolysis. ZA942818B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5254393A 1993-04-23 1993-04-23

Publications (1)

Publication Number Publication Date
ZA942818B true ZA942818B (en) 1995-01-30

Family

ID=21978304

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA942818A ZA942818B (en) 1993-04-23 1994-04-22 Method of enhancing thrombolysis.

Country Status (7)

Country Link
EP (1) EP0701606A4 (fr)
JP (1) JPH08512291A (fr)
AU (1) AU677659B2 (fr)
CA (1) CA2159508A1 (fr)
IL (1) IL109383A0 (fr)
WO (1) WO1994025582A1 (fr)
ZA (1) ZA942818B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4437544A1 (de) * 1994-10-20 1996-04-25 Behringwerke Ag Einsatz von vWF-enthaltenden Konzentraten als Kombinationstherapie bei Therapie mit Antithrombotika und Fibrinolytika

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346571A1 (de) * 1983-12-23 1985-07-04 Bayer Ag, 5090 Leverkusen Oral retardierte acetylsalicylsaeureformulierungen
ATE120206T1 (de) * 1986-05-30 1995-04-15 Scripps Clinic Res Peptide, die die bindung des von-willebrand- faktors inhibieren.
NZ237244A (en) * 1990-03-02 1992-10-28 Bio Technology General Corp Cloning and production of human von willebrand factor analogues and compositions thereof
JPH06502541A (ja) * 1990-10-17 1994-03-24 ザ スクリップス リサーチ インスティテュート フォン・ウィルブランド因子の治療断片
MX9203763A (es) * 1991-06-28 1993-08-01 Rhone Poulenc Rorer Int Polipeptidos terapeuticos a base del factor de von willebrand
AU3734793A (en) * 1992-02-26 1993-09-13 Scripps Research Institute, The Mutant gpibalpha fragments and recombinant expression thereof

Also Published As

Publication number Publication date
JPH08512291A (ja) 1996-12-24
EP0701606A1 (fr) 1996-03-20
IL109383A0 (en) 1994-07-31
CA2159508A1 (fr) 1994-11-10
WO1994025582A1 (fr) 1994-11-10
AU6667694A (en) 1994-11-21
AU677659B2 (en) 1997-05-01
EP0701606A4 (fr) 1999-06-30

Similar Documents

Publication Publication Date Title
GB9419218D0 (en) Methods
ZA939369B (en) Method of milling.
EP0646599A3 (fr) Modification de la toxine pertussis.
GB9305142D0 (en) Method
PH31597A (en) Methods for inhibiting uretine fibrosis.
PL313740A1 (en) Method of
ZA93782B (en) Determination method.
EP0578138A3 (fr) Méthode pour la détection de gènes.
EP0664498A4 (fr) Procede de designation de region.
EP0640836A3 (fr) Méthode d'immunoessai.
GB9306292D0 (en) Method
EP0617335A3 (fr) Méthode d'enregistrement direct.
EP0620201A3 (fr) Procédé pour la préparation des éléments microoptiques.
GB9315306D0 (en) Methods
GB9304026D0 (en) Eyespot method
ZA942818B (en) Method of enhancing thrombolysis.
GB9315340D0 (en) Methods
GB9315351D0 (en) Methods
ZA9610458B (en) Novel method.
GB9323819D0 (en) Anlytical method
EP0628262A3 (fr) Chaussure et son procédé de fabrication.
EP0643417A3 (fr) Méthode pour implanter la porte.
PH31412A (en) Method of treating septic shock using thymosin-alpha 1.
GB9315298D0 (en) Methods
GB9308780D0 (en) Methods